ADB-5'Br-BUTINACA
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C18H25BrN4O2 |
| Molar mass | 409.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug,[1] first detected in Philadelphia in the US in May 2022,[2] and subsequently found in South Korea,[3] Portugal and Sweden.[4] It is specifically listed as an illegal drug in Italy,[5] South Korea[6] and several states in the US,[7][8] and controlled under analogue legislation in various other jurisdictions.
References
- ↑ Deventer MH, Persson M, Norman C, Liu H, Connolly MJ, Daéid NN, McKenzie C, Gréen H, Stove CP (October 2023). "In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs". Drug Testing and Analysis. 16 (6): 616–628. doi:10.1002/dta.3592. hdl:1854/LU-01J55V5XPXHYGHVY60YHRFHZTR. PMID 37903509. S2CID 264671035.
- ↑ "ADB-5'Br-BINACA" (PDF). CFSRE Chemistry Report. The Center for Forensic Science Research & Education.
- ↑ Kim J, Yum H, Kang S, Lee N, Song J, Park Y, Choe S, Park M (November 2023). "Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022". Forensic Science International. 353 111877. doi:10.1016/j.forsciint.2023.111877. PMID 37989071. S2CID 265022768.
- ↑ "Yttrande enligt 13 § Lag (2011:111) om förstörande av vissa hälsofarliga missbrukssubstanser" [Opinion according to § 13 Act (2011:111) on the destruction of certain substances of abuse dangerous to health] (PDF) (in Swedish). The Public Health Authority.
- ↑ "Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella Tabella I di nuove sostanze psicoattive. (23A01072)" [Update of the tables containing the indication of the substances narcotic and psychotropic drugs, referred to in the decree of the President of the Republic 9 October 1990, n. 309 and subsequent amendments e integrations. Inclusion of new substances in Table I psychoactive. (23A01072)] (in Italian). Italy: Ministry of Health. 13 February 2023.
- ↑ "˝에이디비-5'비알-부티나카˝ 등 3종 임시마약류 지정예고" [Announcement of temporary designation of 3 types of narcotics, including “ADB-5 ‘BR-Butinaka’”]. Korean Food and Drug Daily News (in Korean).
- ↑ "18VAC110-20-322. Placement of chemicals in Schedule I." Administrative Code. Commonwealth of Virginia.
- ↑ "Section 19-03.1-05 - Schedule I, N.D. Cent. Code § 19-03.1-05". North Dakota Century Code. Archived from the original on November 25, 2023.
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||